Literature DB >> 15640412

Comparison of temporary and permanent stent placement with concurrent radiation therapy in patients with esophageal carcinoma.

Ji Hoon Shin1, Ho-Young Song, Jong Hoon Kim, Sung-Bae Kim, Gin Hyug Lee, Seung-Il Park, Young-Min Han, Weechang Kang.   

Abstract

PURPOSE: To assess the clinical effectiveness of temporary metallic stent placement with concurrent radiation therapy in patients with esophageal carcinoma by comparing it with permanent stent placement with concurrent radiation therapy.
MATERIALS AND METHODS: Covered retrievable expandable nitinol stents were placed in 47 patients with esophageal carcinoma 1 week before starting radiation therapy; the stents were electively removed 4 weeks after placement in 24 patients (group A), while not electively removed in the other 23 patients (group B). In cases of complications, the stents were also removed from patients in groups A and B. The dysphagia score, complications (severe pain, granulation tissue formation, stent migration, esophagorespiratory fistula, and hematemesis), tumor overgrowth/regrowth, reintervention rates, and dysphagia-progression-free and overall survival rates were compared in the two groups.
RESULTS: Stent placement or removal was technically successful and well tolerated in all patients. The dysphagia score was significantly improved in both groups after stent placement (P < .01). Each of the stent-related complications was less in group A than in group B but there was no significant difference. However, the total number of patients with one or more than one complications and who needed related reinterventions was significantly less in group A than in group B (P = .042 and .030, respectively). Tumor overgrowth/regrowth and the total number of patients who required related reinterventions was not significantly different (P = 1.00 and .517, respectively). Dysphagia-progression-free and overall survival rates were significantly longer in group A than in group B (P = .005 and .001, respectively).
CONCLUSION: Temporary placement of a covered retrievable expandable metallic stent with concurrent radiation therapy for patients with esophageal carcinoma is beneficial for reducing complications and related reinterventions and for increasing resultant survival rates compared with permanent esophageal stent placement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15640412     DOI: 10.1097/01.rvi.0000142585.90055.74

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  15 in total

1.  Retrievable esophageal stents for benign indications.

Authors:  Robert F Wong; Douglas G Adler; Kristen Hilden; John C Fang
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

2.  Woven polydioxanone biodegradable stents: a new treatment option for benign and malignant oesophageal strictures.

Authors:  S M Stivaros; L R Williams; C Senger; L Wilbraham; Hans-Ulrich Laasch
Journal:  Eur Radiol       Date:  2009-11-17       Impact factor: 5.315

3.  Temporary stent placement with concurrent chemoradiation therapy in patients with unresectable oesophageal carcinoma: is there an optimal time for stent removal?

Authors:  Jung-Hoon Park; Ho-Young Song; Ju Yang Park; Jin Hyoung Kim; Yong Hee Kim; Jong-Hoon Kim; Sung-Bae Kim
Journal:  Eur Radiol       Date:  2013-02-21       Impact factor: 5.315

4.  Fluoroscopic removal of retrievable self-expandable metal stents in patients with malignant oesophageal strictures: Experience with a non-endoscopic removal system.

Authors:  Pyeong Hwa Kim; Ho-Young Song; Jung-Hoon Park; Wei-Zhong Zhou; Han Kyu Na; Young Chul Cho; Eun Jung Jun; Jun Ki Kim; Guk Bae Kim
Journal:  Eur Radiol       Date:  2016-06-21       Impact factor: 5.315

5.  The use of biodegradable (SX-ELLA) oesophageal stents to treat dysphagia due to benign and malignant oesophageal disease.

Authors:  Ewen A Griffiths; Catherine J Gregory; Kishore G Pursnani; Jeremy B Ward; Robert C Stockwell
Journal:  Surg Endosc       Date:  2012-03-07       Impact factor: 4.584

6.  History of the Use of Esophageal Stent in Management of Dysphagia and Its Improvement Over the Years.

Authors:  Kulwinder S Dua
Journal:  Dysphagia       Date:  2017-01-18       Impact factor: 3.438

7.  How to design the optimal self-expandable oesophageal metallic stents: 22 years of experience in 645 patients with malignant strictures.

Authors:  Han Kyu Na; Ho-Young Song; Jin Hyoung Kim; Jung-Hoon Park; Min Kyoung Kang; Jongjin Lee; Se Jin Oh
Journal:  Eur Radiol       Date:  2012-09-27       Impact factor: 5.315

8.  Endoscopic stenting: where are we now and where can we go?

Authors:  Mark-Terence McLoughlin; Michael-Francis Byrne
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

Review 9.  Interventions for dysphagia in oesophageal cancer.

Authors:  Yingxue Dai; Chaoying Li; Yao Xie; Xudong Liu; Jianxin Zhang; Jing Zhou; Xiongfei Pan; Shujuan Yang
Journal:  Cochrane Database Syst Rev       Date:  2014-10-30

10.  Evidence-based recommendations on upper gastrointestinal tract stenting: a report from the stent study group of the korean society of gastrointestinal endoscopy.

Authors:  Sam Ryong Jee; Joo Young Cho; Kyung Ho Kim; Sang Gyun Kim; Jun-Hyung Cho
Journal:  Clin Endosc       Date:  2013-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.